D.E. Shaw & Co
WST icon

D.E. Shaw & Co’s West Pharmaceutical WST Stock Holding History

D.E. Shaw & Co’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,400
Closed -$986K – 5828
2022
Q1 		$986K Sell
2,400
-13,900
-85% -$5.44M ﹤0.01% 3928
2021
Q4 		$7.64M Buy
16,300
+3,600
+28% +$1.55M 0.01% 1930
2021
Q3 		$5.39M Buy
+12,700
New +$5.35M ﹤0.01% 2048
2020
Q1 		– Sell
-9,300
Closed -$1.4M – 4312
2019
Q4 		$1.4M Sell
9,300
-900
-9% -$131K ﹤0.01% 2754
2019
Q3 		$1.45M Buy
+10,200
New +$1.4M ﹤0.01% 2595

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co's WST Position: Q1 2026 in Review

D.E. Shaw & Co opened a new position in West Pharmaceutical (WST) in Q1 2026: 14,001 shares worth $3.51M. The stake represents ﹤0.01% of the portfolio and ranks #2452 among its holdings. This is a return to the name: D.E. Shaw & Co previously reported a position in WST as recently as Q3 2025.

D.E. Shaw & Co first reported a position in WST in Q2 2013 and has held it in 36 quarters since. The position peaked at $140M in Q4 2024. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • D.E. Shaw & Co held 14,001 shares of West Pharmaceutical worth $3.51M as of Q1 2026.
  • West Pharmaceutical was a new D.E. Shaw & Co position in Q1 2026.
  • West Pharmaceutical made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2452 holding.
  • D.E. Shaw & Co first reported a position in West Pharmaceutical in Q2 2013 and has held it in 36 quarters since.
  • D.E. Shaw & Co's West Pharmaceutical position peaked at $140M in Q4 2024.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.